Caricamento...
Barriers to Oncology Biosimilars Uptake in the United States
Biosimilars are biological compounds that contain an active substance that is similar to the active substance in an already approved biologic. This commentary focuses on the barriers to the use of biosimilars in the United States.
Salvato in:
| Pubblicato in: | Oncologist |
|---|---|
| Autori principali: | , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
AlphaMed Press
2018
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6291332/ https://ncbi.nlm.nih.gov/pubmed/30049886 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2018-0066 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|